1. Market Research
  2. > Pharmaceutical Market Trends
Market Access Team Structure and Function -- Industry Survey 2017

Market Access Team Structure and Function -- Industry Survey 2017

  • November 2017
  • ID: 5251964

Summary

Table of Contents

This report gives a unique insight into how US and European market access teams are organised and how they are focusing their time on a day-to-day basis.

Market Access Team Structure and Function: Industry Survey 2017 draws on detailed survey responses from 100 market access executives within the top 100 pharmaceutical companies. Presented as easy to assess charts, tables and graphics, plus supporting commentary, this report sheds light on market access priorities, core functions, roles and responsibilities.
Use it to benchmark your market access performance against the industry, and to identify fundamental differences between US and European approaches.

Critical questions answered in this report
• At what point in the development lifecycle are market access resources allocated, which therapeutic areas are covered, and what is the geographical spilt?
• Which functions are kept in-house, and which are commonly outsourced? How is this expected to change over the next 2 years?
• What are the most important core competencies for market access executives, how effectively are they being applied, and how are priorities likely to change in 2 years?
• How much do target and actual prices vary and how long does it take to gain price approval?
• When in the drug lifecycle does first contact occur? How often and via what method do market access teams subsequently engage with stakeholders?
• Pre-launch, how are individual market access activities prioritised, how much cross-functional collaboration occurs, and how useful is it?
• How do post-launch market access priorities and cross-functional interaction differ to pre-launch activity and effectiveness levels?
• How common are pay-for-performance agreements in the US and Europe and how is this likely to change?
• What positive and negative trends and developments are expected to impact market access activity in the future?

Sample of companies who participated in this study:
• GlaxoSmithKline
• Johnson and Johnson
• Novartis
• Pfizer
• Roche
• Sanofi

Critical questions answered in this report
• At what point in the development lifecycle are market access resources allocated, which therapeutic areas are covered, and what is the geographical spilt?
• Which functions are kept in-house, and which are commonly outsourced? How is this expected to change over the next 2 years?
• What are the most important core competencies for market access executives, how effectively are they being applied, and how are priorities likely to change in 2 years?
• How much do target and actual prices vary and how long does it take to gain price approval?
• When in the drug lifecycle does first contact occur? How often and via what method do market access teams subsequently engage with stakeholders?
• Pre-launch, how are individual market access activities prioritised, how much cross-functional collaboration occurs, and how useful is it?
• How do post-launch market access priorities and cross-functional interaction differ to pre-launch activity and effectiveness levels?
• How common are pay-for-performance agreements in the US and Europe and how is this likely to change?
• What positive and negative trends and developments are expected to impact market access activity in the future?

Report Deliverables

This report provides unique data and analysis which can be used to compare market access performance and shape resource and activity plans.
• Data Study: 30 clear and concise charts that depict the current state and future outlook for market access activity and performance assessment
• Data Tabulations: All survey data is provided in MS Excel

Key Takeaways
• Review how market access teams are broken down by role as well as the level of external support utilised for core functions
• Find out which market access activities are seen as most important in the US and Europe
• Benchmark your market access activity and identify key areas for performance improvement
• Understand the approach to key areas such as resource allocation, communication timing and frequency, and inter-functional collaboration
• Assess the critical differences in pre- and post-launch strategies for US as European market access teams
• Identify the most widely used channels for stakeholder interaction both before and after launch
• Discover the level of uptake of pay-for-performance agreements, including expectations for the future. Compare with your team’s performance and goals

About the Survey

Interviewing methodology
Data were collected via a 25-minute internet-based questionnaire

Screening criteria

Respondents were screened to ensure that:
• they are employees of a top 100 pharma company
• they have responsibilities for developing and/or executing market access strategy

Sample distribution

100 US-/EU5-based market access executives who work for pharmaceutical companies ranked in the top 100 by revenue

Unique features – not available elsewhere
• Current insights from 100 senior market access executives based in the US and Europe
• A variety of indicators to benchmark your market access performance against the industry
• A clear indication of timings for core activities pre- and post-launch
• Details of resource allocation
• A direct comparison of US versus European market access activity levels and priorities.

Table of Contents

Market access team roles and responsibilities
• Regional responsibility of market access teams
• Geographical split of operational resources
• Therapeutic area coverage
• Market access team roles

Market access functions, operations and core competencies
• In-house versus outsourced market access functions
• Field-based versus office-based market access operations
• Importance of market access core competencies
• Effectiveness of implementation of core competencies
• Changing importance of market access core competencies

Resource allocation and communication
• Timing of market access resources

• Frequency of market access team interactions
• Timing of initial communication with stakeholders

Pre- and post-launch activities and cross-functional collaboration
• Pre-launch market access activities
• Post-launch market access activities
• Pre-launch cross-functional collaboration
• Post-launch cross-functional collaboration

Product launch and pricing
• Timing of resource allocation
• Differences between planned and actual time to launch
• Differences between planned and actual time to price approval
• Differences between target and actual price
• Past pay-for-performance agreements
• Future pay-for-performance agreements

Pre- and post-launch channels for interaction with stakeholders
• Stakeholder interaction channels pre-launch
• Stakeholder interaction channels post-launch

Trends and developments in market access

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Benign Prostatic Hyperplasia - Pipeline Review, H2 2018

Benign Prostatic Hyperplasia - Pipeline Review, H2 2018

  • $ 2000
  • November 2018

Benign Prostatic Hyperplasia - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperplasia - Pipeline Review, H2 2018, ...

Global Transdermal Drug Delivery System Market - Opportunities and Forecast (2013-2023)

Global Transdermal Drug Delivery System Market - Opportunities and Forecast (2013-2023)

  • $ 2400
  • November 2018

Executive SummaryA comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the ...

Epidermolysis Bullosa - Pipeline Review, H2 2018

Epidermolysis Bullosa - Pipeline Review, H2 2018

  • $ 2000
  • October 2018

Epidermolysis Bullosa - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2018, provides an ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on